levofloxacin has been researched along with Clostridioides difficile Infection in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (13.64) | 29.6817 |
| 2010's | 15 (68.18) | 24.3611 |
| 2020's | 4 (18.18) | 2.80 |
| Authors | Studies |
|---|---|
| Courter, JD; Dandoy, CE; Davies, SM; Gardner, JC; Teusink-Cross, A | 1 |
| Álvarez-Pérez, S; Anega, B; Blanco, JL; García, ME; Hernández, M | 1 |
| Grosdidier, J; Laible, BR; Nazir, J | 1 |
| Andremont, A; Burdet, C; Corbel, T; de Gunzburg, J; Ferreira, S; Mentré, F; Nevière, A; Pulse, M; Sablier-Gallis, F; Saint-Lu, N; Sayah-Jeanne, S; Weiss, W | 1 |
| Freifeld, A; Liewer, S; Shostrom, VK; Signorelli, J; Zimmer, A | 1 |
| Cheng, JW; Fan, X; Hou, X; Kudinha, T; Liang, GW; Liu, C; Shao, DH; Su, JR; Wang, Y; Wei, M; Xiao, M; Xiong, ZJ; Xu, YC; Yang, CX; Yang, QW; Yu, SY | 1 |
| Caliendo, G; Kim, SS; Koseck, K; Meyer, J; Steinberg, A | 1 |
| Chen, HX; Luo, YP; Shen, YY; Song, LJ; Suo, L; Wang, R | 1 |
| Flynn, PM; Gaur, AH; Hakim, H; Hayden, RT; Inaba, H; Jeha, S; Pui, CH; Stewart, T; Sun, Y; Tang, L; Wolf, J | 1 |
| Fulford, AE; Lee, SSF; Quinn, MA; Rajakumar, I; Seabrook, J | 1 |
| Abuderman, AA; Mateen, A; Sawsan Aloahd, M; Syed, R | 1 |
| Barrado, L; Ezpeleta-Baquedano, C; Navascués, A; Torroba-Álvarez, L | 1 |
| Bilker, W; Bink, K; Fitzpatrick, R; Gilmar, C; Gorman, T; Han, JH; Kraus, K; Kucharczuk, C; Landsburg, D; Mangan, P; Moore, A; Pegues, D; Stadtmauer, EA; Ziegler, M | 1 |
| Chopra, V; Conlon, A; Flanders, SA; Gandhi, T; Malani, AN; Vaughn, VM | 1 |
| Kaufman, E; Liska, D; Nandakumar, G; Rubinshteyn, V | 1 |
| Chen, YH; Hsueh, PR; Huang, CH; Lai, CC | 1 |
| Gergis, U; Jacobs, SE; Mark, TM; Satlin, MJ; Shore, TB; Soave, R; Vardhana, S; Walsh, TJ | 1 |
| Gerding, DN; Johnson, S; Nagaro, K; Phillips, ST; Sambol, SP | 1 |
| Fortier, LC; Meessen-Pinard, M; Sekulovic, O | 1 |
| Gaynes, R; Johnson, TM; Killgore, G; Killum, E; Lowery, HK; Rimland, D; Tenover, FC | 1 |
| Go, ES; Khurana, A; Recco, RA; Vinayek, N; Zaman, MM | 1 |
| Ozawa, TT; Valadez, T | 1 |
2 review(s) available for levofloxacin and Clostridioides difficile Infection
| Article | Year |
|---|---|
Clostridium colicanis bacteraemia in an asthmatic patient diagnosed as acute respiratory infection.
Topics: Aged; Anti-Bacterial Agents; Asthma; Bacteremia; Cefotaxime; Clostridium; Clostridium Infections; Diagnostic Errors; Drug Therapy, Combination; Female; Humans; Immunocompetence; Levofloxacin; Respiratory Tract Infections | 2019 |
The potential role of nemonoxacin for treatment of common infections.
Topics: Anti-Bacterial Agents; Chlamydia Infections; Clostridium Infections; Community-Acquired Infections; Drug Therapy, Combination; Gonorrhea; Humans; Levofloxacin; Pneumonia, Bacterial; Quinolones; Skin Diseases, Bacterial | 2015 |
1 trial(s) available for levofloxacin and Clostridioides difficile Infection
| Article | Year |
|---|---|
Levofloxacin Prophylaxis During Induction Therapy for Pediatric Acute Lymphoblastic Leukemia.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteremia; Bacterial Infections; Child; Child, Preschool; Clostridium Infections; Cohort Studies; Drug Resistance, Microbial; Female; Humans; Induction Chemotherapy; Levofloxacin; Logistic Models; Male; Neutropenia; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2017 |
19 other study(ies) available for levofloxacin and Clostridioides difficile Infection
| Article | Year |
|---|---|
Safety and Efficacy of Prophylactic Levofloxacin in Pediatric and Adult Hematopoietic Stem Cell Transplantation Patients.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacterial Infections; Child; Child, Preschool; Clostridium Infections; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Infant; Levofloxacin; Retrospective Studies; Young Adult | 2022 |
In vitro activity of fidaxomicin and combinations of fidaxomicin with other antibiotics against Clostridium perfringens strains isolated from dogs and cats.
Topics: Animals; Anti-Bacterial Agents; Cat Diseases; Cats; Clindamycin; Clostridioides difficile; Clostridium Infections; Clostridium perfringens; Diarrhea; Dog Diseases; Dogs; Erythromycin; Fidaxomicin; Humans; Imipenem; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Vancomycin | 2023 |
Developing an antimicrobial stewardship program across a rural health system: The Avera Health experience.
Topics: Anti-Bacterial Agents; Antimicrobial Stewardship; Clostridioides difficile; Clostridium Infections; Drug Resistance, Bacterial; Drug Utilization; Hospitals, Rural; Humans; Levofloxacin; Microbial Sensitivity Tests; Pharmacists; Pharmacy Service, Hospital; Professional Role; Program Development; Program Evaluation; Rural Health Services | 2019 |
DAV131A Protects Hamsters from Lethal
Topics: Administration, Oral; Adsorption; Animals; Anti-Bacterial Agents; Charcoal; Ciprofloxacin; Clostridioides difficile; Clostridium Infections; Disease Models, Animal; Dysbiosis; Fluoroquinolones; Gastrointestinal Microbiome; Levofloxacin; Male; Mesocricetus | 2019 |
Incidence of Febrile Neutropenia in Autologous Hematopoietic Stem Cell Transplant (HSCT) Recipients on levofloxacin prophylaxis.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteremia; Clostridium Infections; Febrile Neutropenia; Female; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Levofloxacin; Male; Middle Aged; Retrospective Studies; Transplant Recipients; Transplantation, Autologous; Transplantation, Homologous | 2020 |
The tcdA-negative and tcdB-positive Clostridium difficile ST81 clone exhibits a high level of resistance to fluoroquinolones: a multi-centre study in Beijing, China.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; China; Ciprofloxacin; Clostridioides difficile; Clostridium Infections; DNA Gyrase; Drug Resistance, Bacterial; Enterotoxins; Fluoroquinolones; Humans; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Molecular Epidemiology; Molecular Typing; Moxifloxacin; Vancomycin | 2020 |
Comparison of the rates of Clostridium difficile and bacteremia after delaying fluoroquinolone prophylaxis from day 0 to day +3 post autologous stem cell transplantation.
Topics: Adult; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteremia; Clostridioides difficile; Clostridium Infections; Female; Fluoroquinolones; Hematopoietic Stem Cell Transplantation; Humans; Levofloxacin; Male; Middle Aged; Retrospective Studies; Transplantation, Autologous; Young Adult | 2017 |
Molecular epidemiology and antimicrobial susceptibility of Clostridium difficile isolated from the Chinese People's Liberation Army General Hospital in China.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; China; Clindamycin; Clostridioides difficile; Clostridium Infections; Diarrhea; Drug Resistance, Bacterial; Female; Genotype; Hospitals, General; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Epidemiology; Multilocus Sequence Typing; Vancomycin; Young Adult | 2018 |
Levofloxacin for febrile neutropenia prophylaxis in acute myeloid leukemia patients associated with reduction in hospital admissions.
Topics: Adult; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy-Induced Febrile Neutropenia; Clostridium Infections; Consolidation Chemotherapy; Female; Hospitalization; Humans; Leukemia, Myeloid, Acute; Levofloxacin; Male; Middle Aged; Retrospective Studies | 2018 |
Molecular characterization of Clostridium difficile isolated from carriage and association of its pathogenicity to prevalent toxic genes.
Topics: Adolescent; ADP Ribose Transferases; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; Clindamycin; Clostridioides difficile; Clostridium Infections; Diarrhea; Drug Resistance, Bacterial; Enterotoxins; Feces; Female; Genes, Bacterial; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Epidemiology; Prevalence; Prospective Studies; Risk Factors; Virulence; Young Adult | 2018 |
Fluoroquinolone Prophylaxis Is Highly Effective for the Prevention of Central Line-Associated Bloodstream Infections in Autologous Stem Cell Transplant Patients.
Topics: Adult; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteremia; Clostridium Infections; Febrile Neutropenia; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Infection Control; Infections; Levofloxacin; Male; Middle Aged; Sepsis; Transplantation, Autologous | 2019 |
The Association of Antibiotic Stewardship With Fluoroquinolone Prescribing in Michigan Hospitals: A Multi-hospital Cohort Study.
Topics: Aged; Anti-Bacterial Agents; Antimicrobial Stewardship; Ciprofloxacin; Clostridium Infections; Cohort Studies; Drug Prescriptions; Drug Resistance, Bacterial; Female; Fluoroquinolones; Hospitals; Humans; Levofloxacin; Male; Michigan; Moxifloxacin; Pneumonia; Retrospective Studies; Risk; Surveys and Questionnaires | 2019 |
Clostridium difficile bacteremia.
Topics: Anti-Bacterial Agents; Bacteremia; Clostridioides difficile; Clostridium Infections; Humans; Intestinal Perforation; Levofloxacin; Lymphoma, Mantle-Cell; Male; Metronidazole; Middle Aged; Treatment Outcome; Vancomycin | 2013 |
Impact of Prophylactic Levofloxacin on Rates of Bloodstream Infection and Fever in Neutropenic Patients with Multiple Myeloma Undergoing Autologous Hematopoietic Stem Cell Transplantation.
Topics: Antibiotic Prophylaxis; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Bacteremia; Clostridioides difficile; Clostridium Infections; Combined Modality Therapy; Drug Resistance, Microbial; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Febrile Neutropenia; Female; Filgrastim; Guideline Adherence; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Incidence; Levofloxacin; Lymphoma; Male; Melphalan; Middle Aged; Multiple Myeloma; Practice Guidelines as Topic; Retrospective Studies; Risk Factors; Transplantation Conditioning; Transplantation, Autologous | 2015 |
Susceptibility of hamsters to infection by historic and epidemic BI Clostridium difficile strains during daily administration of three fluoroquinolones.
Topics: Animals; Anti-Bacterial Agents; Aza Compounds; Ciprofloxacin; Clostridioides difficile; Clostridium Infections; Cricetinae; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Levofloxacin; Male; Mesocricetus; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Prohibitins; Quinolines | 2011 |
Evidence of in vivo prophage induction during Clostridium difficile infection.
Topics: Anti-Bacterial Agents; Aza Compounds; Base Sequence; Ciprofloxacin; Clostridioides difficile; Clostridium Infections; DNA, Viral; Feces; Fluoroquinolones; Genetic Variation; Genome, Viral; Humans; Levofloxacin; Lysogeny; Microbial Sensitivity Tests; Mitomycin; Molecular Sequence Data; Moxifloxacin; Myoviridae; Ofloxacin; Prophages; Quinolines; Sequence Analysis, DNA; Virus Activation | 2012 |
Outbreak of Clostridium difficile infection in a long-term care facility: association with gatifloxacin use.
Topics: Case-Control Studies; Clostridioides difficile; Clostridium Infections; Cross Infection; Diarrhea; Disease Outbreaks; Drug Resistance, Bacterial; Fluoroquinolones; Follow-Up Studies; Gatifloxacin; Humans; Levofloxacin; Long-Term Care; Microbial Sensitivity Tests; Ofloxacin | 2004 |
The incidence of Clostridium difficile-associated and non-C. difficile-associated diarrhea after use of gatifloxacin and levofloxacin in an acute-care facility.
Topics: Clostridioides difficile; Clostridium Infections; Diarrhea; Emergency Medical Services; Fluoroquinolones; Gatifloxacin; Humans; Incidence; Levofloxacin; Ofloxacin | 2004 |
Clostridium difficile infection associated with levofloxacin treatment.
Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Clostridioides difficile; Clostridium Infections; Diarrhea; Feces; Female; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Risk Factors | 2002 |